Reporting the counterparty's growth as its own: management explains the company's coming year by narrating what its cust
The model's full reasoning — Q1 2024 call → NOWe need to determine if management explains the company's business direction by narrating what its counterparties are doing and scaling. The question asks: does a substantial part of management's forward account consist of reporting on the growth, expansion, ramp, adoption, or program build-out of specific customers, partners, licensees, distributors, payers, operators, or programs the company already supplies or serves, such that the company's own coming volume is presented as a consequence of those parties' own trajectories? We need to look at the transcript. Management (Mike Simonds and Kelly Tuminelli) discuss their performance, sales, retention, insurance costs, etc. They talk about their own sales efforts, distribution expansion, tenured reps, channel partners. They mention that they are seeing strong sales and retention. They talk about the broader economic environment for SMBs. They mention healthcare cost trends. They talk about their strategy review. Do they narrate what specific counterparties are doing? They mention "customers" and "channel partners" but not specific named companies or programs. They talk about "our customers' hiring" and "normalization of insurance costs." They mention that they are seeing increased utilization and cost inflation. They mention a ransomware attack on Change Healthcare, a claim processor, but that's not a counterparty they supply; it's a third-party processor. They don't describe any specific customer's expansion or ramp. They talk about their own sales growth, retention, and expense management. They talk about their go-to-market investments. They talk about their strategy review. They do not describe any specific counterparty's own trajectory as the driver of their coming activity. They mention that they are seeing strong demand from customers generally, but not specific ones. Thus, the answer is NO. The forward account is based on their own actions and broad market conditions, not on narrating specific counterparties' scaling. So answer NO.
| Ticker | Company | Call | Date | Call grade |
|---|---|---|---|---|
| EMKR | EMCORE Corporation | Q4 2023 | 2023-12-12 | C+ |
| MBLY | Mobileye Global Inc. | Q2 2023 | 2023-07-28 | B+ |
| PI | Impinj, Inc. | Q4 2022 | 2023-02-08 | B+ |
| FAT | FAT Brands Inc. | Q4 2021 | 2022-03-21 | F |
| OOMA | Ooma, Inc. | Q3 2022 | 2021-12-02 | B+ |
| ILMN | Illumina, Inc. | Q1 2018 | 2018-04-24 | A |
| PLAB | Photronics, Inc. | Q2 2017 | 2017-05-17 | C+ |
| IONS | Ionis Pharmaceuticals, Inc. | Q1 2017 | 2017-05-09 | C |
| FNV | Franco-Nevada Corporation | Q3 2016 | 2016-11-08 | B+ |
| HXL | Hexcel Corporation | Q4 2015 | 2016-01-22 | B+ |
OOMA · Q3 2022 → YESThe question is about whether management narrates what its counterparties are doing and scaling, presenting the company's future volume as a consequence of those parties' trajectories.
MBLY · Q2 2023 → YESThe question is about whether management narrates what its counterparties are doing and scaling, presenting the company's volume as a consequence of those parties' trajectories.
ILMN · Q1 2018 → YESThe question is about whether management narrates what its counterparties are doing and scaling, presenting the company's future as a consequence of those parties' trajectories.